145 related articles for article (PubMed ID: 22172512)
1. Depth and volume of resorption induced by osteoclasts generated in the presence of RANKL, TNF-alpha/IL-1 or LIGHT.
Mabilleau G; Pascaretti-Grizon F; Baslé MF; Chappard D
Cytokine; 2012 Feb; 57(2):294-9. PubMed ID: 22172512
[TBL] [Abstract][Full Text] [Related]
2. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM; Nishioka K; Yudoh K
Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
[TBL] [Abstract][Full Text] [Related]
3. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
Edwards JR; Sun SG; Locklin R; Shipman CM; Adamopoulos IE; Athanasou NA; Sabokbar A
Arthritis Rheum; 2006 May; 54(5):1451-62. PubMed ID: 16649193
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro.
Pfeilschifter J; Chenu C; Bird A; Mundy GR; Roodman GD
J Bone Miner Res; 1989 Feb; 4(1):113-8. PubMed ID: 2785743
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid macrophages are capable of osteoclast formation and resorption.
Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
[TBL] [Abstract][Full Text] [Related]
6. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis.
Colucci S; Brunetti G; Cantatore FP; Oranger A; Mori G; Quarta L; Cirulli N; Mancini L; Corrado A; Grassi FR; Grano M
J Pathol; 2007 May; 212(1):47-55. PubMed ID: 17370327
[TBL] [Abstract][Full Text] [Related]
8. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1beta and tumor necrosis factor-alpha produce distinct, time-dependent patterns of acute arthritis in the rat knee.
Bolon B; Campagnuolo G; Zhu L; Duryea D; Zack D; Feige U
Vet Pathol; 2004 May; 41(3):235-43. PubMed ID: 15133172
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
11. Bone and joint destruction in rheumatoid arthritis: what is really happening?
Goldring SR
J Rheumatol Suppl; 2002 Sep; 65():44-8. PubMed ID: 12236623
[TBL] [Abstract][Full Text] [Related]
12. Dual modulation of osteoclast differentiation by lipopolysaccharide.
Zou W; Bar-Shavit Z
J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
[TBL] [Abstract][Full Text] [Related]
13. Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes.
Kim YG; Lee CK; Oh JS; Kim SH; Kim KA; Yoo B
Arthritis Rheum; 2010 Feb; 62(2):515-23. PubMed ID: 20112365
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.
Kohara H; Kitaura H; Fujimura Y; Yoshimatsu M; Morita Y; Eguchi T; Masuyama R; Yoshida N
Immunol Lett; 2011 Jun; 137(1-2):53-61. PubMed ID: 21338623
[TBL] [Abstract][Full Text] [Related]
16. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
Adamopoulos IE; Wordsworth PB; Edwards JR; Ferguson DJ; Athanasou NA
Hum Pathol; 2006 Sep; 37(9):1176-85. PubMed ID: 16938523
[TBL] [Abstract][Full Text] [Related]
17. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
18. [Role of tumor necrosis factor family ligands in the pathogenesis of rheumatoid arthritis--new therapeutical opportunities].
Kmieć Z; Sokołowska I
Pol Merkur Lekarski; 2007 Apr; 22(130):300-4. PubMed ID: 17684931
[TBL] [Abstract][Full Text] [Related]
19. Measurement by vertical scanning profilometry of resorption volume and lacunae depth caused by osteoclasts on dentine slices.
Pascaretti-Grizon F; Mabilleau G; Basle MF; Chappard D
J Microsc; 2011 Feb; 241(2):147-52. PubMed ID: 21118208
[TBL] [Abstract][Full Text] [Related]
20. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
